Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

NCT00029328 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

FED

Sponsor class

Conditions

Respiratory Distress Syndrome, Adult
Bronchiolitis Obliterans
Pneumonia

Interventions

DRUG: etanercept

Sponsor

FDA Office of Orphan Products Development